ProPhase Labs Ownership | Who Owns ProPhase Labs?

Overview Forecast RevenueFinancials Chart Transcripts

ProPhase Labs Ownership Summary

ProPhase Labs is owned by 9.17% institutional investors, 14.34% insiders, and 76.50% retail investors. Vanguard group is the largest institutional shareholder, holding 3.64% of PRPH shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.90% of its assets in ProPhase Labs shares.

PRPH Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	ProPhase Labs	9.17%	14.34%	76.50%
Sector	Healthcare Stocks	88.01%	8.90%	3.09%
Industry	Specialty & Generic Drug Manufacturers Stocks	34.23%	10.67%	55.10%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	655.95K	3.64%	$2.74M
Renaissance	220.51K	1.22%	$921.73K
Sheets smith wealth management	208.30K	1.09%	$157.70K
Hightower advisors	151.37K	0.84%	$633.00K
Geode capital management	147.15K	0.82%	$615.21K
Perritt capital management	85.50K	0.47%	$357.39K
Blackrock	64.30K	0.36%	$268.77K
Susquehanna group, llp	62.48K	0.35%	$261.16K
Chapin davis	50.00K	0.26%	$121.00K
State street	44.66K	0.25%	$186.69K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Perritt capital management	85.50K	0.20%	$357.39K
Chapin davis	50.00K	0.04%	$121.00K
Sheets smith wealth management	208.30K	0.02%	$157.70K
Bridgeway capital management	22.96K	0.00%	$95.98K
Renaissance	220.51K	0.00%	$921.73K
Hightower advisors	151.37K	0.00%	$633.00K
Vanguard group	655.95K	0.00%	$2.74M
Commonwealth equity services	13.36K	0.00%	$56.00K
Geode capital management	147.15K	0.00%	$615.21K
Svb wealth	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Sheets smith wealth management	208.30K	0.02%	208.30K
Vanguard group	655.95K	0.00%	37.18K
Barclays	11.77K	-	11.77K
Geode capital management	147.15K	0.00%	8.73K
Susquehanna group, llp	62.48K	-	7.83K

Top Sellers

Holder	Shares	% Assets	Change
Svb wealth	-	-	-47.66K
Goldman sachs group	-	-	-23.79K
Adviser investments	-	-	-22.00K
Renaissance	220.51K	0.00%	-14.30K
Tower research capital llc (trc)	-	-	-10.57K

New Positions

Holder	Shares	% Assets	Change	Value
Sheets smith wealth management	208.30K	0.02%	208.30K	$157.70K
Barclays	11.77K	-	11.77K	$49.00K
Group one trading	705.00	-	705.00	$2.95K

Sold Out

Holder	Change
Qube research	-25.00
Spire wealth management	-80.00
Capital advisors	-190.00
Concourse financial group securities	-292.00
Ubs group	-3.32K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	25	-16.67%	1,748,647	0.58%	9	9.87%	11	-8.33%	3	-57.14%
Jun 30, 2024	30	-6.25%	1,738,576	2.48%	9	9.91%	12	9.09%	7	-36.36%
Mar 31, 2024	32	18.52%	1,696,529	1.46%	9	10.40%	11	-	11	37.50%
Dec 31, 2023	27	-25.00%	1,672,165	-13.87%	9	7.33%	11	-8.33%	8	-46.67%
Sep 30, 2023	36	-23.40%	1,941,537	-9.99%	11	6.95%	12	-45.45%	15	7.14%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	454.64K	1.90%	-
Vanguard Institutional Extnd Mkt Idx Tr	181.39K	0.76%	-
Fidelity Extended Market Index	87.12K	0.36%	-574.00
Perritt MicroCap Opportunities Investor	40.00K	0.21%	-
Belfund SICAV Belinvest Equity A USD Acc	50.00K	0.21%	-
iShares Micro-Cap ETF	38.37K	0.16%	-
BlackRock Extended Equity Market K	23.33K	0.12%	-10.00
Perritt Ultra MicroCap	20.00K	0.10%	-
Extended Equity Market Fund K	23.01K	0.10%	-317.00
Fidelity Total Market Index	22.22K	0.09%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 10, 2022	Barr Jason Michael	-	Buy	$4.67K
Mar 10, 2022	Barr Jason Michael		Buy	$4.86K
Jun 03, 2021	Karkus Ted William	CEO & CHAIRMAN	Buy	$171.92K
Aug 13, 2020	Karkus Ted William	CEO & CHAIRMAN	Sell	$137.50K
Aug 13, 2020	GLECKEL LOUIS MD	-	Buy	$137.50K

Insider Transactions Trends

Date	Buy	Sell
2023 Q2	-	-
2023 Q1	-	-
2022 Q4	-	-
2022 Q3	-	-
2022 Q2	-	-

PRPH Ownership FAQ

Who Owns ProPhase Labs?

ProPhase Labs shareholders are primarily institutional investors at 9.17%, followed by 14.34% insiders and 76.49% retail investors. The average institutional ownership in ProPhase Labs's industry, Specialty & Generic Drug Manufacturers Stocks, is 34.23%, which ProPhase Labs falls below.

Who owns the most shares of ProPhase Labs?

ProPhase Labs’s largest shareholders are Vanguard group (655.95K shares, 3.64%), Renaissance (220.51K shares, 1.22%), and Sheets smith wealth management (208.3K shares, 1.09%). Together, they hold 5.95% of ProPhase Labs’s total shares outstanding.

Does Blackrock own ProPhase Labs?

Yes, BlackRock owns 0.36% of ProPhase Labs, totaling 64.3K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 268.77K$. In the last quarter, BlackRock increased its holdings by 6.94K shares, a 12.10% change.

Who is ProPhase Labs’s biggest shareholder by percentage of total assets invested?

Perritt capital management is ProPhase Labs’s biggest shareholder by percentage of total assets invested, with 0.20% of its assets in 85.5K ProPhase Labs shares, valued at 357.39K$.

Who is the top mutual fund holder of ProPhase Labs shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of ProPhase Labs shares, with 1.90% of its total shares outstanding invested in 454.64K ProPhase Labs shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools